Follow The Filings

CRSPCrispr Therapeutics AG

Q1 2022 13F holders among managers we track Latest ownership dossier

Ticker
CRSP
Type
Equity
Class
NAMEN AKT
Total reported value (long equity)
Manager Report date Value Shares